Recombinant Human CST3 Protein，His

CST3, or Cystatin C, is a cysteine protease inhibitor that plays a crucial role in various physiological and pathological processes, including immune response, tissue remodeling, and neurodegenerative diseases. Studies have shown that CST3 is significantly involved in the regulation of proteolytic enzymes, influencing cellular functions and interacting with key pathways in inflammation and apoptosis. The reorganization of CST3 into recombinant proteins offers a promising approach to elucidate its functional roles and therapeutic potentials. Recent research has highlighted the importance of CST3 in the context of Alzheimer's disease, where its reduced levels are associated with increased amyloid-beta aggregation, contributing to the progression of neurodegeneration. Furthermore, CST3 has been studied for its potential implications in cancer biology, where it may modulate tumor progression and metastasis through its regulatory effects on the microenvironment. By producing recombinant CST3 proteins, researchers can better explore its structural properties, interactions with other proteins, and mechanisms of action. This understanding could lead to novel diagnostic and therapeutic strategies aimed at targeting CST3-related pathways, thereby enhancing the treatment of diseases such as neurodegeneration and cancer. Consequently, the investigation of CST3 recombinant proteins represents a vital area of study with significant implications for advancing our knowledge of disease mechanisms and developing innovative therapeutic interventions.